EtOH, Sucrose and sodium saccharin were used as drinking solutions. EtOH (99.8%) solutions (PanReac AppliChem, Barcelona, Spain) diluted to 5, 10, 20, 30 or 40% (v/v) were prepared in sterilized tap water. Sucrose solutions were prepared by dissolving ≥ 99.5% Sucrose (Sigma-Aldrich Química S.A. Madrid, Spain) in sterilized tap water to 5, 10, 20 or 40% (w/v). Sodium saccharine (Sigma-Aldrich, ≥ 98%) solutions at 0.13, 0.26, 0.53 or 1.06% (w/v) were dissolved in sterilized tap water. Concentrations of all drinking solutions were based on previous studies (Rhodes et al., 2005 (link), 2007 (link); Kamdar et al., 2007 ; Pastor et al., 2011 (link); Tarragón et al., 2012 (link)) as well as on our own pilot studies. In the case of EtOH, a direct study of the influence of availability of different concentrations and number of tubes was included in the present study (Experiment 1). NTX hydrochloride (Sigma-Aldrich) was diluted in 0.9% physiological saline and administered intraperitoneally (IP; 10 mL/kg injection volume). The dose range of NTX (4, 8 or 16 mg/kg) used in the present study was based on previous work (Kamdar et al., 2007 ; Tarragón et al., 2012 (link); Fultz et al., 2017 (link)).